<DOC>
	<DOCNO>NCT01072591</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single intravenous dose MEDI-578 , monoclonal antibody , patient osteoarthritis knee . It also evaluate MEDI-578 absorb distribute body .</brief_summary>
	<brief_title>Study Assess MEDI -578 Patients With Osteoarthritis ( OA ) Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patients painful osteoarthritis knee . The pain knee must exceed pain experienced condition . Patients must willing able discontinue current analgesic treatment . Any form arthritis osteoarthritis . Presence neuropathic pain , fibromyalgia , wide spread chronic pain related osteoarthritis . Significant abnormality clinical examination may interfere study present safety risk patient , judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>anti-NGF</keyword>
	<keyword>OA</keyword>
	<keyword>pain</keyword>
</DOC>